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ABSTRACT 
The search of novel mPGES-1 inhibitors has recently intensified probably due to the superior 
safety in comparison to existing anti-inflammatory drugs. Although two mPGES-1 inhibitors 
have entered clinical trials, none has yet reached the market. In this study, we performed 
modifications guided by 3D-QSAR CoMFA on 2, which is an unsymmetrical curcumin derivative 
with low binding affinity towards mPGES-1. To counter the PAINS properties predicted for 2, 
the diketone linker was replaced with a pyrazole ring. On the other hand, both prenyl and 
carboxylate ester groups were introduced to improve the activity. When tested in vitro, 11 
suppressed PGE2 biosynthesis in activated macrophages and showed promising human mPGES-
1 inhibition in microsomes of interleukin-1β-stimulated A549 cells. Altogether, 11 has been 
identified as a potential mPGES-1 inhibitor and could be a promising lead for a novel class of 
mPGES-1 inhibitors. 
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